MedTrace Logo

Lipiodol Localization for Ground-glass-opacity Minimal Surgery

NCT02180568 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2018-03-22

No results posted yet for this study

Summary

The study object is to demonstrate the usefulness and safety of lipiodol localization technique for individuals undergoing ground-glass opacity (GGO) Video-assisted thoracic surgery (VATS) resection compared to hook wire localization technique. A total of 250 participants will be enrolled in a 1:1 fashion to Lipiodol or Hook-wire groups. If the aims of this study are achieved, the use of lipiodol localization technique will be widespread their application for localization of non-palpable pulmonary lesions that are indicated for VATS resection.

Conditions

  • Pulmonary Lesion With Ground-glass-opacity

Interventions

PROCEDURE

Lipiodol

Lipiodol-guided lung localization technique

PROCEDURE

Hookwire

Hookwire-guided lung localization technique

DRUG

Lipiodol

Sponsors & Collaborators

  • Gangnam Severance Hospital

    collaborator OTHER

  • Asan Medical Center

    collaborator OTHER

  • Pusan National University Hospital

    collaborator OTHER

  • Korea University Anam Hospital

    collaborator OTHER

  • Chung-Ang University Hosptial, Chung-Ang University College of Medicine

    collaborator OTHER

  • Dankook University

    collaborator OTHER

  • Wonju Severance Christian Hospital

    collaborator OTHER

  • Severance Hospital

    lead OTHER

Principal Investigators

  • Jin Hur, M.D.,Ph.D. · Yonsei University Health System, Severance Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-12-31
Completion
2017-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02180568 on ClinicalTrials.gov